Circulating Levels of Omentin, Leptin, VEGF, and HGF and Their Clinical Relevance with PSA Marker in Prostate Cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating Levels of Omentin, Leptin, VEGF, and HGF and Their Clinical Relevance with PSA Marker in Prostate Cancer
Authors
Keywords
-
Journal
DISEASE MARKERS
Volume 2018, Issue -, Pages 1-9
Publisher
Hindawi Limited
Online
2018-08-17
DOI
10.1155/2018/3852401
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RON and c-Met facilitate metastasis through the ERK signaling pathway in prostate cancer cells
- (2017) Binbin Yin et al. ONCOLOGY REPORTS
- Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis
- (2017) Michał Kukla et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Serum leptin: A marker of prostate cancer irrespective of obesity
- (2017) S.K. Singh et al. Cancer Biomarkers
- The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study
- (2016) Farshid Dayyani et al. BMC CANCER
- Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal and ovarian cancer screening trial
- (2016) Jiaqi Huang et al. BRITISH JOURNAL OF CANCER
- Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years
- (2016) Paul F. Pinsky et al. CANCER
- Circulating Omentin as a Novel Biomarker for Colorectal Cancer Risk: Data from the EPIC–Potsdam Cohort Study
- (2016) Krasimira Aleksandrova et al. CANCER RESEARCH
- Circulating levels of adipocytokine omentin-1 in patients with renal cell cancer
- (2016) Xu-Dong Shen et al. CYTOKINE
- Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial
- (2016) Scott P. Kelly et al. JNCI-Journal of the National Cancer Institute
- Prostate Specific Antigen-Growth Curve Model to Predict High-Risk Prostate Cancer
- (2016) Azza Shoaibi et al. PROSTATE
- The influence of PSA autoantibodies in prostate cancer patients: a prospective clinical study-II
- (2016) Kosei Nakajima et al. Oncotarget
- Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial
- (2016) Scott P. Kelly et al. JNCI-Journal of the National Cancer Institute
- Complex relationship between sex hormones, insulin resistance and leptin in men with and without prostatic disease
- (2015) Halina Grosman et al. Aging Male
- Circulating adiponectin, leptin and adiponectin-leptin ratio and endometrial cancer risk: Evidence from a meta-analysis of epidemiologic studies
- (2015) Ting-Ting Gong et al. INTERNATIONAL JOURNAL OF CANCER
- Leptin influences estrogen metabolism and accelerates prostate cell proliferation
- (2015) Christine N. Habib et al. LIFE SCIENCES
- Omentin serum concentration and hepatic expression in chronic hepatitis C patients – together or apart?
- (2015) Michał Kukla et al. POLISH JOURNAL OF PATHOLOGY
- Intelectin 1 suppresses tumor progression and is associated with improved survival in gastric cancer
- (2015) Dan Li et al. Oncotarget
- Leptin and leptin receptor expressions in prostate tumors may predict disease aggressiveness?
- (2014) Clarice F. Osório et al. Acta Cirurgica Brasileira
- Regulation of hepatocyte growth factor expression by NF-κB and PPARγ in adipose tissue
- (2014) Jun Yin et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Efficacy and Toxicity of Anti-VEGF Agents in Patients with Castration-Resistant Prostate Cancer: a Meta-analysis of Prospective Clinical Studies
- (2014) Wei-Xiang Qi et al. Asian Pacific Journal of Cancer Prevention
- The role of leptin in gastric cancer: Clinicopathologic features and molecular mechanisms
- (2014) Kang Nyeong Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
- (2014) Andrew J Vickers et al. BMC Medicine
- Type 2 diabetes and the risk of mortality among patients with prostate cancer
- (2014) Leah Bensimon et al. CANCER CAUSES & CONTROL
- Association of C-peptide and leptin with prostate cancer incidence in the Health Professionals Follow-up Study
- (2014) Gabriel Y. Lai et al. CANCER CAUSES & CONTROL
- Omentin: Linking Metabolic Syndrome and Cardiovascular Disease
- (2014) Ji-Yin Zhou et al. Current Vascular Pharmacology
- Diabetes mellitus and the risk of prostate cancer: an update and cumulative meta-analysis
- (2014) Pan Jian Gang et al. ENDOCRINE RESEARCH
- Diabetes mellitus and risk of prostate cancer in the EuropeanProspectiveInvestigation into Cancer and Nutrition
- (2014) Konstantinos K. Tsilidis et al. INTERNATIONAL JOURNAL OF CANCER
- Serum omentin level in patients with prostate cancer
- (2014) Ugur Uyeturk et al. MEDICAL ONCOLOGY
- Role of RUNX3 in Suppressing Metastasis and Angiogenesis of Human Prostate Cancer
- (2014) Feifei Chen et al. PLoS One
- Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
- (2013) Virginia A. Moyer ANNALS OF INTERNAL MEDICINE
- Diabetes Mellitus and Prostate Cancer Risk; A Nationwide Case-Control Study within PCBaSe Sweden
- (2013) K. Fall et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Insulin and Leptin Levels in Obese Patients With and Without Breast Cancer
- (2013) Maria Del Socorro Romero-Figueroa et al. Clinical Breast Cancer
- Circulating levels of novel adipocytokines in patients with colorectal cancer
- (2013) Mohammad Sadegh Fazeli et al. CYTOKINE
- Prospective Investigation of Body Mass Index, Colorectal Adenoma, and Colorectal Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
- (2013) Cari M. Kitahara et al. JOURNAL OF CLINICAL ONCOLOGY
- Multifaceted Leptin Network: The Molecular Connection Between Obesity and Breast Cancer
- (2013) Neeraj K. Saxena et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- The Association between Leptin Level and Breast Cancer: A Meta-Analysis
- (2013) Jingping Niu et al. PLoS One
- Association between metabolic syndrome, diabetes mellitus and prostate cancer risk
- (2013) Y R Lawrence et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: the ProtecT study
- (2012) Anya Burton et al. CANCER CAUSES & CONTROL
- Omentin plays an anti-inflammatory role through inhibition of TNF-α-induced superoxide production in vascular smooth muscle cells
- (2012) Kyosuke Kazama et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Omentin-1, a new adipokine, promotes apoptosis through regulating Sirt1-dependent p53 deacetylation in hepatocellular carcinoma cells
- (2012) Yuan-Yuan Zhang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Elevated Insulin and Insulin Resistance Are Associated with the Advanced Pathological Stage of Prostate Cancer in Korean Population
- (2012) Seok Joong Yun et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Dichotomous effects of VEGF-A on adipose tissue dysfunction
- (2012) K. Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Leptin Regulates Proliferation and Apoptosis in Human Prostate
- (2012) Eduardo Leze et al. TheScientificWorldJOURNAL
- Aberrant expression of intelectin-1 in gastric cancer: its relationship with clinicopathological features and prognosis
- (2011) Liduan Zheng et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Profiling of differentially expressed proteins in stage IV Colorectal cancers with good and poor outcomes
- (2011) Hye-Jung Kim et al. Journal of Proteomics
- Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes
- (2010) Hong-Yan Pan et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Drug development of MET inhibitors: targeting oncogene addiction and expedience
- (2008) Paolo M. Comoglio et al. NATURE REVIEWS DRUG DISCOVERY
- Serum active hepatocyte growth factor (AHGF) in benign prostatic disease and prostate cancer
- (2008) Kenji Yasuda et al. PROSTATE
- Contribution of a Single Repeat PSA Test to Prostate Cancer Risk Assessment: Experience from the ProtecT Study
- (2007) Derek J. Rosario et al. EUROPEAN UROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started